Saphenous-jugular bypass as palliative therapy of superior vena cava syndrome caused by bronchial carcinoma.
This study discusses the techniques and results of the saphenous-jugular bypass procedure. The operation was introduced into Hungarian medical practice and used for palliation of superior vena cava syndrome (SVCS) resulting from malignant disease. The bypass operation was performed on seven patients to relieve symptoms of SVCS caused by unresectable bronchial carcinoma. Postoperative survival times averaged 6.1 months. The symptoms of SVCS were relieved in all patients and did not recur. This study also compares the operative results of the saphenous-jugular bypass operation with results of the widely known operative techniques.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D002283:Carcinoma, Bronchogenic / Q000150:complications* / Q000188:drug therapy / Q000401:mortality; D002294:Carcinoma, Squamous Cell / Q000150:complications; D006801:Humans; D007601:Jugular Veins / Q000601:surgery*; D008175:Lung Neoplasms / Q000150:complications* / Q000188:drug therapy / Q000401:mortality; D008875:Middle Aged; D012501:Saphenous Vein / Q000601:surgery*; D013577:Syndrome; D014683:Vena Cava, Superior
D000970:Antineoplastic Agents